Literature DB >> 5005285

Characteristics of complement-dependent release of phospholipid from Escherichia coli.

L A Wilson, J K Spitznagel.   

Abstract

The release of (32)P-labeled bacterial phospholipid from a smooth Escherichia coli by serum components depends on complement activated by antibody. Phospholipid release in excess antibody tends to be proportional to the concentration of complement as does the release of other cellular constituents. Phospholipids are not simply stripped off during cell lysis. Whereas 94% of the total phospholipid freed from E. coli by mechanical lysis sediments at centrifugal forces sufficient to sediment molecules of 10(6) molecular weight, similar centrifugation sediments only 50% of the phospholipid released by antibody-complement. In fact, after mechanical lysis more than 50% of the phospholipid sediments at velocities sufficient to bring down cell envelopes. Although the bulk of the bacterial phospholipid is located in the cell envelopes, isolated (32)P-labeled cell envelopes and phenol-extracted lipopolysaccharide fails to release phospholipids in the presence of antibody-complement. Moreover, ethylenediaminetetraacetic acid, which like antibody-complement causes loss of cellular selective permeability and prepares E. coli cell walls for the action of lysozyme, releases only small amounts of phospholipid from E. coli and these are sedimentable. The most likely mechanism of phospholipid release caused by antibody-complement appears to be the activation directly or indirectly of an enzyme which is present only in the intact cells.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5005285      PMCID: PMC416258          DOI: 10.1128/iai.4.1.23-28.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Molecular and structural damage to Escherichia coli produced by antibody, complement, and lysozyme systems.

Authors:  L A Wilson; J K Spitznagel
Journal:  J Bacteriol       Date:  1968-10       Impact factor: 3.490

2.  The effect of ethylenediaminetetra-acetic acid on the cell walls of some gram-negative bacteria.

Authors:  G W Gray; S G Wilkinson
Journal:  J Gen Microbiol       Date:  1965-06

3.  Serum complement and the enzymatic degradation of erythrocyte phospholipid.

Authors:  J K Smith; E L Becker
Journal:  J Immunol       Date:  1968-03       Impact factor: 5.422

Review 4.  Bacterial lipids.

Authors:  M Kates
Journal:  Adv Lipid Res       Date:  1964

5.  Release of lipopolysaccharide by EDTA treatment of E. coli.

Authors:  L Leive
Journal:  Biochem Biophys Res Commun       Date:  1965-11-22       Impact factor: 3.575

6.  Lipids of Salmonella typhimurium and Escherichia coli: structure and metabolism.

Authors:  G F Ames
Journal:  J Bacteriol       Date:  1968-03       Impact factor: 3.490

7.  Normal serum cytotoxicity for P32-labeled smooth Enterobacteriaceae. I. Loss of label, death, and ultrastructural damage.

Authors:  J K Spitznagel; L A Wilson
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

8.  Normal serum cytotoxicity for P32-labeled smooth Enterobacteriaceae. II. Fate of macromolecular and lipid phosphorus of damaged cells.

Authors:  J K Spitznagel
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

9.  Interactions of the complement system with the surface and endotoxic lipopolysaccharide of Veillonella alcalescens.

Authors:  H A Bladen; H Gewurz; S E Mergenhagen
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307

10.  Reversal of the bactericidal reaction of serum by magnesium ion.

Authors:  L H Muschel; J E Jackson
Journal:  J Bacteriol       Date:  1966-04       Impact factor: 3.490

View more
  9 in total

1.  Release of 14C label and complement killing of Escherichia coli.

Authors:  B M Wilson; A A Glynn
Journal:  Immunology       Date:  1975-03       Impact factor: 7.397

2.  Interaction of complement and polymyxin with gram-negative bacteria.

Authors:  H Pruul; B L Reynolds
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

3.  Effects of human and rabbit serum on viability, permeability, and envelope lipids of Serratia marcescens.

Authors:  S Beckerdite-Quagliata; M Simberkoff; P Elsbach
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

Review 4.  The membrane attack complex.

Authors:  H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

Review 5.  Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

Authors:  P W Taylor
Journal:  Microbiol Rev       Date:  1983-03

6.  Partial characterization and purification of a rabbit granulocyte factor that increases permeability of Escherichia coli.

Authors:  J Weiss; R C Franson; S Beckerdite; K Schmeidler; P Elsbach
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

Review 7.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

8.  Sequential metabolic expressions of the lethal process in human serum-treated Escherichia coli: role of lysozyme.

Authors:  R J Martinez; S F Carroll
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

9.  Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.

Authors:  S I Rosenfeld; C H Packman; J P Leddy
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.